SEC Form 4 · accession 0001645627-17-000057
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 8, 2017
Accepted (ET)
May 9, 2017 · 3:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 8, 2017 | P | 1,000 | $0.0749 | A | 20,662,949 | D | |
| Common Stock | May 8, 2017 | P | 1,000 | $0.075 | A | 20,663,949 | D | |
| Common Stock | May 8, 2017 | P | 1,000 | $0.072 | A | 20,664,949 | D | |
| Common Stock | May 8, 2017 | P | 200 | $0.0676 | A | 20,665,149 | D | |
| Common Stock | May 8, 2017 | P | 800 | $0.0675 | A | 20,665,949 | D | |
| Common Stock | May 8, 2017 | P | 1,000 | $0.072 | A | 20,666,949 | D | |
| Common Stock | May 8, 2017 | P | 1,000 | $0.072 | A | 20,667,949 | D | |
| Common Stock | May 8, 2017 | P | 1,000 | $0.0697 | A | 20,668,949 | D | |
| Common Stock | May 8, 2017 | P | 1,000 | $0.07 | A | 20,669,949 | D | |
| Common Stock | May 8, 2017 | P | 1,000 | $0.074 | A | 20,670,949 | D | |
| Common Stock | May 8, 2017 | P | 1,000 | $0.0779 | A | 20,671,949 | D | |
| Common Stock | May 8, 2017 | P | 1,000 | $0.077 | A | 20,672,949 | D |
Table II — derivative securities
No Table II lines on this filing.